ArticleERJ open research2025

Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications.

Tejaswini Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.